Getting Prolastin-C Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization, Appeals, and State External Review
Answer Box: Prolastin-C Coverage with Blue Cross Blue Shield in Virginia
Blue Cross Blue Shield Virginia requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) for alpha-1 antitrypsin deficiency. Coverage requires documented severe AATD (like Pi*ZZ genotype), clinical evidence of emphysema, and lung function tests showing moderate impairment (typically FEV1 35-60%